蛋白药物
Protein drugs

惠升生物发挥两大平台技术优势，瞄准市场重要、紧急的产品，开发具有巨大市场前景和适合现有技术平台特点的生物蛋白药物。
PhytoDerProtein Corp plays two major platform technology advantages, aimed at the market important, urgent products, develop biological protein drugs have huge market prospects and are suitable for the characteristics of the existing technology.

科研试剂
Research reagents

惠升生物利用新一代植物反应器技术，将生产科研试剂做为产业化第一阶段的发展方向。
PhytoDerProtein Corp uses a new generation of plant reactor technology, and makes produce scientific research reagents as the development direction of first phase of the industrialization.

技术服务
Technical service

惠升生物将采取技术服务、技术转让、技术许可、技术投资等多种方式，打造植物分子医药产业集群。
PhytoDerProtein Corp will take technical services, technology transfer, technology licensing, technology investment and other means to build plant molecular medicine industry cluster.

精准医疗
Precision medicine

惠升生物与一流三甲医院合作，根据个体健康差异，制定个性化的重大疾病预防和治疗方案。
PhytoDerProtein Corp cooperates with the top three hospitals, and according to individual health differences, formulates personalized major disease prevention and treatment programs.